Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02793219
Title Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center, Houston

prostate adenocarcinoma


Docetaxel + Sipuleucel-T

Age Groups: adult
Covered Countries USA

No variant requirements are available.